Retrospective study of paclitaxel plus ramucirumab in patients with advanced or recurrent gastric cancer with ascites
Latest Information Update: 06 May 2021
At a glance
- Drugs Paclitaxel (Primary) ; Ramucirumab (Primary)
- Indications Gastric cancer
- Focus Adverse reactions; Therapeutic Use
Most Recent Events
- 25 Jan 2020 Results presented at the 2020 Gastrointestinal Cancers Symposium
- 30 Aug 2018 New trial record